Quansheng Bio-B (ASX: 02509) has announced the execution of a share repurchase transaction.
The company disclosed that on June 26, 2026, it utilized HK$65,600 to repurchase 4,800 of its own shares.
The buyback was conducted at a price range of HK$13.58 to HK$13.69 per share.